The John van Geest Cancer Research Centre Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2017
NCT02872675
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

galactooligosaccharide (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1